Skip to main content
. 2021 Jan 4;20(1):1–7. doi: 10.18502/cjn.v20i1.6373

Table 3.

Adverse events (AEs) and serious adverse events (SAEs)

AEs
P SAEs
P
Case (n = 10) Control (n = 10) Case (n = 10) Control (n = 10)
Gait disturbance 3 5 0.65
Dysphagia 4 2 0.62
Muscular weakness 7 8 > 0.99 1 0 > 0.99
Constipation 3 0 0.21
Myalgia 2 5 0.35
Anemia 1 0 > 0.99
Hyperglycemia 0 2 0.47
Total 20 22 1 0

AE: Adverse event; SAE: Serious adverse event

All P-values were calculated by chi-square test